Izopet J - Search Results

1

Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, Wedemeyer H, Dalton HR. Kamar N, et al. Among authors: izopet j. Nat Rev Dis Primers. 2017 Nov 16;3:17086. doi: 10.1038/nrdp.2017.86. Nat Rev Dis Primers. 2017. PMID: 29154369 Review.

2

Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.

Rostaing L, Oksman F, Izopet J, Baron E, Cisterne JM, Hoff M, Abbal M, Durand D. Rostaing L, et al. Among authors: izopet j. Am J Nephrol. 1996;16(6):478-83. doi: 10.1159/000169047. Am J Nephrol. 1996. PMID: 8955758

3

Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.

Sandres K, Dubois M, Pasquier C, Payen JL, Alric L, Duffaut M, Vinel JP, Pascal JP, Puel J, Izopet J. Sandres K, et al. Among authors: izopet j. J Virol. 2000 Jan;74(2):661-8. doi: 10.1128/jvi.74.2.661-668.2000. J Virol. 2000. PMID: 10623727 Free PMC article.

4

Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil.

Rostaing L, Izopet J, Sandres K, Cisterne JM, Puel J, Durand D. Rostaing L, et al. Among authors: izopet j. Transplantation. 2000 Mar 15;69(5):991-4. doi: 10.1097/00007890-200003150-00055. Transplantation. 2000. PMID: 10755563

5

Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.

Malavaud B, Dinh B, Bonnet E, Izopet J, Payen JL, Marchou B. Malavaud B, et al. Among authors: izopet j. Antivir Ther. 2000 Mar;5(1):3-5. Antivir Ther. 2000. PMID: 10846585

6

Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients.

Kamar N, Kany M, Bories P, Ribes D, Izopet J, Durand D, Rostaing L. Kamar N, et al. Among authors: izopet j. Am J Kidney Dis. 2001 Apr;37(4):E29. doi: 10.1016/s0272-6386(01)90015-0. Am J Kidney Dis. 2001. PMID: 11273899

7

Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.

Kamar N, Rostaing L, Boulestin A, Sandres K, Dubois M, Ribes D, Modesto A, Durand D, Izopet J. Kamar N, et al. Among authors: izopet j. J Med Virol. 2003 Apr;69(4):482-8. doi: 10.1002/jmv.10335. J Med Virol. 2003. PMID: 12601755

8

Screening for hepatitis B virus DNA in serum of organ donors and renal transplant recipients.

Miédougé M, Rostaing L, Mansuy JM, Sandres-Sauné K, Boudet F, Izopet J. Miédougé M, et al. Among authors: izopet j. Eur J Clin Microbiol Infect Dis. 2003 Apr;22(4):246-8. doi: 10.1007/s10096-003-0889-3. Epub 2003 Mar 25. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12709839

9

[Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].

Kamar N, Sandres-Saune K, Selves J, Durand D, Izopet J, Rostaing L. Kamar N, et al. Among authors: izopet j. Nephrologie. 2003;24(2):89-94. Nephrologie. 2003. PMID: 12723514 French.

10

[Hepatitis C infection among patients receiving hemodialysis].

Kamar N, Izopet J, Rostaing L. Kamar N, et al. Among authors: izopet j. Nephrologie. 2003;24(3):133-41. Nephrologie. 2003. PMID: 12814060 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

688 results

Search Page

Filters